Explore more publications!
Vanuatu Health Times
Submit Press Release

Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 12, 2025

ProText Mobility, Inc. Provides Shareholder Update
September 12, 2025

ProText Mobility, Inc. Provides Shareholder Update

Indeterminate GlobeNewswire
Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 12, 2025

Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Vystar® to restart sales of Vytex® Cloud Bed-in-a-Box 
September 12, 2025

Vystar® to restart sales of Vytex® Cloud Bed-in-a-Box 

Indeterminate GlobeNewswire
Intuitive Introduces Real-Time Surgical Insights for da Vinci 5
September 12, 2025

Intuitive Introduces Real-Time Surgical Insights for da Vinci 5

Indeterminate GlobeNewswire
American Kidney Fund Convenes Kidney Community Members for Sixth Annual Summit on Unknown Causes of Kidney Disease
September 12, 2025

American Kidney Fund Convenes Kidney Community Members for Sixth Annual Summit on Unknown Causes of Kidney Disease

Indeterminate GlobeNewswire
Olympia Pharmaceuticals Wins Orlando Business Journal’s Family-Owned Business Award
September 12, 2025

Olympia Pharmaceuticals Wins Orlando Business Journal’s Family-Owned Business Award

Indeterminate GlobeNewswire
HealthLynked Strengthens Intellectual Property Portfolio with New Patent Filings in AI and Patient Record Management
September 12, 2025

HealthLynked Strengthens Intellectual Property Portfolio with New Patent Filings in AI and Patient Record Management

Indeterminate GlobeNewswire
24/7 Market News: Kraig Labs Positioned at the Forefront of the Next-Gen Materials Revolution
September 12, 2025

24/7 Market News: Kraig Labs Positioned at the Forefront of the Next-Gen Materials Revolution

Indeterminate GlobeNewswire
ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer
September 12, 2025

ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer

Indeterminate GlobeNewswire
Interim results for the six months ended June 30, 2025
September 12, 2025

Interim results for the six months ended June 30, 2025

Indeterminate GlobeNewswire
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 12, 2025

InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire
Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End
September 12, 2025

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End

Indeterminate GlobeNewswire
FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies
September 12, 2025

FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies

Indeterminate GlobeNewswire
Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference
September 12, 2025

Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference

Indeterminate GlobeNewswire
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor
September 12, 2025

ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor

Indeterminate GlobeNewswire
Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
September 12, 2025

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

Indeterminate GlobeNewswire
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner
September 12, 2025

Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner

Indeterminate GlobeNewswire
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study
September 12, 2025

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

Indeterminate GlobeNewswire
Progress in clinical development for Alzheimer’s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator
September 12, 2025

Progress in clinical development for Alzheimer’s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions